MiR-18a has been reported in many cancer types, including prostate cancer, gastric cancer, nasopharyngeal carcinoma, esophageal squamous cell carcinoma and breast cancer. Nevertheless, the role of miR-18a remains unclear in bladder cancer.
MiR-18a has been reported in many cancer types, including prostate cancer, gastric cancer, nasopharyngeal carcinoma, esophageal squamous cell carcinoma and breast cancer. Nevertheless, the role of miR-18a remains unclear in bladder cancer.